日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow

ARCAD-Asia倡议:利用昨日数据展望未来

Takeda, Y; Misumi, T; Bando, H; Suzuki, M; Wakabayashi, M; Oki, E; Yamazaki, K; Kakeji, Y; Shitara, K; Terashima, M; Raeisi, M; Maehara, Y; Ohtsu, A; Andre, T; de Gramont, A; Shi, Q; Yoshino, T

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7

针对对标准疗法无效的转移性结直肠癌患者,根据 RAS 突变状态评估三氟尿苷/替吡嘧啶联合贝伐单抗的 II 期研究:JFMC51-1702-C7

Takahashi, T; Yamazaki, K; Oki, E; Shiozawa, M; Mitsugi, K; Makiyama, A; Nakamura, M; Ojima, H; Kagawa, Y; Matsuhashi, N; Okuda, H; Asayama, M; Yuasa, Y; Shimada, Y; Manaka, D; Watanabe, J; Oba, K; Yoshino, T; Yoshida, K; Maehara, Y

Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5)

元素饮食对接受多西他赛/顺铂/5-氟尿嘧啶治疗的食管癌患者减少不良事件的影响:一项 III 期随机对照试验-EPOC 2 (JFMC49-1601-C5)

Tanaka, Y; Takeuchi, H; Nakashima, Y; Nagano, H; Ueno, T; Tomizuka, K; Morita, S; Emi, Y; Hamai, Y; Hihara, J; Saeki, H; Oki, E; Kunisaki, C; Otsuji, E; Baba, H; Matsubara, H; Maehara, Y; Kitagawa, Y; Yoshida, K

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.

肝切除术后肝细胞癌炎症生物标志物的预后意义

Itoh S, Yugawa K, Shimokawa M, Yoshiya S, Mano Y, Takeishi K, Toshima T, Maehara Y, Mori M, Yoshizumi T

A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)

一项随机 III 期试验比较 S-1 与 UFT 作为 II/III 期直肠癌辅助化疗的疗效(JFMC35-C1:ACTS-RC)

Oki, E; Murata, A; Yoshida, K; Maeda, K; Ikejiri, K; Munemoto, Y; Sasaki, K; Matsuda, C; Kotake, M; Suenaga, T; Matsuda, H; Emi, Y; Kakeji, Y; Baba, H; Hamada, C; Saji, S; Maehara, Y

Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan

日本九州地区食管癌合并胃切除术患者的临床特征及治疗:一项多中心问卷调查

Okumura, H; Mori, N; Tanaka, T; Morita, M; Toh, Y; Saeki, H; Maehara, Y; Nakamura, K; Honda, H; Yoshida, N; Baba, H; Natsugoe, S

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

鉴定血清外泌体中预测肝细胞癌肝移植术后复发的真正microRNA生物标志物

Sugimachi, K; Matsumura, T; Hirata, H; Uchi, R; Ueda, M; Ueo, H; Shinden, Y; Iguchi, T; Eguchi, H; Shirabe, K; Ochiya, T; Maehara, Y; Mimori, K

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer

循环肿瘤细胞衍生的plastin3是预测乳腺癌患者长期预后的新型标志物

Ueo, H; Sugimachi, K; Gorges, T M; Bartkowiak, K; Yokobori, T; Müller, V; Shinden, Y; Ueda, M; Ueo, H; Mori, M; Kuwano, H; Maehara, Y; Ohno, S; Pantel, K; Mimori, K

Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C

丙型肝炎患者脾脏CD8+ T细胞耗竭的特征

Sumida, K; Shimoda, S; Iwasaka, S; Hisamoto, S; Kawanaka, H; Akahoshi, T; Ikegami, T; Shirabe, K; Shimono, N; Maehara, Y; Selmi, C; Gershwin, M E; Akashi, K

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases

miR-144-ZFX轴在胃癌骨髓播散性肿瘤细胞中的临床意义

Akiyoshi, S; Fukagawa, T; Ueo, H; Ishibashi, M; Takahashi, Y; Fabbri, M; Sasako, M; Maehara, Y; Mimori, K; Mori, M